MARKET

NBRVF

NBRVF

Nabriva Therapeutics Plc
EXMKT
0.0002
NaN%
Closed 09:30 03/28 EDT
OPEN
--
PREV CLOSE
0.0002
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
8.45
52 WEEK LOW
0.0001
MARKET CAP
646.17
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NBRVF last week (0408-0412)?
Weekly Report · 1d ago
Weekly Report: what happened at NBRVF last week (0401-0405)?
Weekly Report · 04/08 10:18
Weekly Report: what happened at NBRVF last week (0325-0329)?
Weekly Report · 04/01 10:17
Weekly Report: what happened at NBRVF last week (0318-0322)?
Weekly Report · 03/25 10:19
Weekly Report: what happened at NBRVF last week (0311-0315)?
Weekly Report · 03/18 10:18
Weekly Report: what happened at NBRVF last week (0304-0308)?
Weekly Report · 03/11 10:16
Weekly Report: what happened at NBRVF last week (0226-0301)?
Weekly Report · 03/04 10:18
Weekly Report: what happened at NBRVF last week (0219-0223)?
Weekly Report · 02/26 10:25
More
About NBRVF
Nabriva Therapeutics PLC is a biopharmaceutical company. The Company is engaged in the commercialization, research and development of novel anti-infective agents to treat serious infections. Its products include SIVEXTRO and XENLETA, as well as one development product candidate, CONTEPO. SIVEXTRO product is an oxazolidinone class antibiotic to treat susceptible Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). XENLETA product is designed to inhibit the synthesis of a specific protein on the bacterial ribosome, which is required for bacteria to grow, by binding with high affinity and specificity at molecular targets that are different than other available antibiotic classes causing cell death. CONTEPO is an investigational IV antibiotic in the United States with a spectrum of Gram-negative and Gram-positive activity, including activity against MDR strains, such as extended-spectrum β-lactamase-, or ESBL-producing Enterobacteriaceae.

Webull offers Nabriva Therapeutics PLC - ADR stock information, including EXMKT: NBRVF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBRVF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBRVF stock methods without spending real money on the virtual paper trading platform.